MA41157A - Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenant de l'azote bicyclique en tant que composant actif - Google Patents

Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenant de l'azote bicyclique en tant que composant actif

Info

Publication number
MA41157A
MA41157A MA041157A MA41157A MA41157A MA 41157 A MA41157 A MA 41157A MA 041157 A MA041157 A MA 041157A MA 41157 A MA41157 A MA 41157A MA 41157 A MA41157 A MA 41157A
Authority
MA
Morocco
Prior art keywords
pharmaceutical composition
active component
compound containing
aromatic heterocyclic
composition consisting
Prior art date
Application number
MA041157A
Other languages
English (en)
Inventor
Takeyuki Nagashima
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of MA41157A publication Critical patent/MA41157A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA041157A 2014-12-09 2015-12-07 Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenant de l'azote bicyclique en tant que composant actif MA41157A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014249348 2014-12-09

Publications (1)

Publication Number Publication Date
MA41157A true MA41157A (fr) 2017-10-17

Family

ID=56107385

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041157A MA41157A (fr) 2014-12-09 2015-12-07 Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenant de l'azote bicyclique en tant que composant actif

Country Status (15)

Country Link
US (1) US20170360779A1 (fr)
EP (1) EP3231424A1 (fr)
JP (1) JPWO2016093202A1 (fr)
KR (1) KR20170088881A (fr)
CN (1) CN107106557A (fr)
AU (1) AU2015362515A1 (fr)
BR (1) BR112017012376A2 (fr)
CA (1) CA2970226A1 (fr)
IL (1) IL252664A0 (fr)
MA (1) MA41157A (fr)
MX (1) MX2017007640A (fr)
RU (1) RU2017120189A (fr)
SG (1) SG11201704590RA (fr)
TW (1) TW201634050A (fr)
WO (1) WO2016093202A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020008A1 (fr) * 2000-09-06 2002-03-14 The Scripps Research Institute Oxidoreductase d'ubiquinone utilisee comme inhibiteur de nadh
HK1220446A1 (en) * 2013-06-10 2017-05-05 Astellas Pharma Inc. Bicyclic nitrogen-containing aromatic heterocyclic amide compound

Also Published As

Publication number Publication date
KR20170088881A (ko) 2017-08-02
RU2017120189A (ru) 2019-01-11
WO2016093202A1 (fr) 2016-06-16
EP3231424A1 (fr) 2017-10-18
CN107106557A (zh) 2017-08-29
AU2015362515A1 (en) 2017-06-29
SG11201704590RA (en) 2017-07-28
JPWO2016093202A1 (ja) 2017-09-14
MX2017007640A (es) 2017-09-11
US20170360779A1 (en) 2017-12-21
BR112017012376A2 (pt) 2018-04-24
IL252664A0 (en) 2017-08-31
CA2970226A1 (fr) 2016-06-16
TW201634050A (zh) 2016-10-01

Similar Documents

Publication Publication Date Title
CU20170015A7 (es) Compuesto de (pirazolilamino) pirimidinil biciclo (3.2.1)oct-8-il
CR20130487A (es) 1,3-oxazinas como inhibidores de BACE1 y/o BACE2
DOP2019000193A (es) Nuevo compuesto heterocíclico, su método de preparación y composición farmacéutica que lo comprende
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
FR26C1014I1 (fr) Compositions pharmaceutiques contenant de l'insuline
MX2018004008A (es) Inhibidores de isoindolinona de la interaccion mdm2-p53 que tienen actividad antineoplasica.
EP3059227A4 (fr) Sel de composé hétérocyclique contenant de l'azote ou cristal de ce dernier, composition pharmaceutique et inhibiteur de flt3
EP3373932A4 (fr) Forme cristalline d'un composé de quinoline substituée et composition pharmaceutique en contenant
ME03775B (fr) Composition médicinale comprenant un composé de carboxamide hétérocyclique diamino en tant qu'agent actif
MX391489B (es) Inhibidores heterociclicos de mct4.
MX2018003993A (es) Inhibidores de isoindolinona de la interaccion mdm2-p53 que tienen actividad antineoplasica.
EP3398947A4 (fr) Composé hétérocyclique condensé contenant de l'azote, ainsi que procédé de préparation, intermédiaire, composition et application associés
EP3012256A4 (fr) Composé hétérocyclique de benzimidazole-2-pipérazine, composition pharmaceutique le contenant, procédé de préparation et d'utilisation associé
EP3360551A4 (fr) Composition pharmaceutique contenant un composé d'arylalkylamine
MX383069B (es) Farmaceutico que contiene inhibidor de transportador de fosfato dependiente de sodio.
EP3372231A4 (fr) Composition pharmaceutique pour l'immunothérapie anticancéreuse et/ou pour l'immunostimulation, contenant comme principe actif un composé diamino carboxamide hétérocyclique
EP3327000A4 (fr) Nouveau composé ayant une activité inhibitrice de blt et composition pour prévenir ou traiter des maladies inflammatoires, le contenant en tant que principe actif
CL2017002229A1 (es) Inhibidores de bace1.
EP2815759A4 (fr) Composition pharmaceutique contenant en tant qu'ingrédient actif un extrait provenant de l'écorce de liriodendron tulipifera
EP3327004A4 (fr) Composé hétérocyclique contenant de l'azote
MA41158A (fr) Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenat de l'azote bicyclique en tant que principe actif
MA41157A (fr) Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenant de l'azote bicyclique en tant que composant actif
EP3381904A4 (fr) Nouveau composé hétérocyclique aromatique contenant de l'azote
EP3417857A4 (fr) Composition pharmaceutique contenant un dérivé d'imidazoline
TH169293A (th) สารยับยั้ง bacei